105027,Admission,O
105027,Date,O
105027,:,O
105027,[,O
105027,**2125-9-18**,O
105027,],O
105027,Discharge,O
105027,Date,O
105027,:,O
105027,[,O
105027,**2125-10-8**,O
105027,],O
105027,Date,O
105027,of,O
105027,Birth,O
105027,:,O
105027,[,O
105027,**2088-6-30**,O
105027,],O
105027,Sex,O
105027,:,O
105027,F,O
105027,Service,O
105027,:,O
105027,MEDICINE,O
105027,Allergies,O
105027,:,O
105027,Sulfa,B-Drug
105027,(,I-Drug
105027,Sulfonamide,I-Drug
105027,Antibiotics,I-Drug
105027,),I-Drug
105027,/,O
105027,Codeine,B-Drug
105027,/,O
105027,Shellfish,O
105027,Derived,O
105027,Attending,O
105027,:,O
105027,[,O
105027,**Doctor,O
105027,First,O
105027,Name,O
105027,2080**,O
105027,],O
105027,Chief,O
105027,Complaint,O
105027,:,O
105027,Thrombocytopenia,O
105027,Major,O
105027,Surgical,O
105027,or,O
105027,Invasive,O
105027,Procedure,O
105027,:,O
105027,Right,O
105027,IJ,O
105027,line,O
105027,PICC,O
105027,line,O
105027,placement,O
105027,History,O
105027,of,O
105027,Present,O
105027,Illness,O
105027,:,O
105027,This,O
105027,is,O
105027,a,O
105027,37,O
105027,year,O
105027,old,O
105027,female,O
105027,who,O
105027,presented,O
105027,to,O
105027,OSH,O
105027,with,O
105027,5,O
105027,days,O
105027,of,O
105027,LLQ/left,O
105027,flank,O
105027,pain,O
105027,.,O
105027,She,O
105027,was,O
105027,initially,O
105027,seen,O
105027,at,O
105027,[,O
105027,**Hospital3,O
105027,**,O
105027,],O
105027,on,O
105027,[,O
105027,**9-14**,O
105027,],O
105027,and,O
105027,was,O
105027,diagnosed,O
105027,with,O
105027,a,O
105027,ruptured,B-Reason
105027,ovarian,I-Reason
105027,cyst,I-Reason
105027,on,O
105027,TVUS,O
105027,;,O
105027,she,O
105027,was,O
105027,discharged,O
105027,on,O
105027,oxycodone-APAP,B-Drug
105027,.,I-Drug
105027,On,O
105027,[,O
105027,**9-15**,O
105027,],O
105027,she,O
105027,developed,O
105027,subjective,O
105027,fevers/rigors,O
105027,",",O
105027,increased,O
105027,pain,O
105027,",",O
105027,and,O
105027,shortness,O
105027,of,O
105027,breath,O
105027,with,O
105027,exertion,O
105027,.,O
105027,Over,O
105027,the,O
105027,weekend,O
105027,her,O
105027,pain,O
105027,became,O
105027,more,O
105027,diffuse,O
105027,",",O
105027,across,O
105027,the,O
105027,upper,O
105027,abdomen,O
105027,.,O
105027,She,O
105027,then,O
105027,re-presented,O
105027,on,O
105027,[,O
105027,**9-18**,O
105027,],O
105027,to,O
105027,[,O
105027,**Hospital6,O
105027,33**,O
105027,],O
105027,",",O
105027,where,O
105027,workup,O
105027,included,O
105027,a,O
105027,CT,O
105027,abdomen/pelvis,O
105027,with,O
105027,evidence,O
105027,of,O
105027,pyelonephritis,B-Reason
105027,.,I-Reason
105027,She,O
105027,was,O
105027,given,O
105027,a,O
105027,dose,O
105027,of,O
105027,levofloxacin,B-Drug
105027,",",I-Drug
105027,IV,O
105027,hydromorphone,B-Drug
105027,",",I-Drug
105027,and,O
105027,a,O
105027,undefinded,O
105027,amount,O
105027,of,O
105027,IVF,B-Drug
105027,.,I-Drug
105027,Her,O
105027,labs,O
105027,also,O
105027,showed,O
105027,platelets,O
105027,of,O
105027,69K,O
105027,",",O
105027,low,O
105027,WBC,O
105027,",",O
105027,and,O
105027,low,O
105027,hematocrit,O
105027,around,O
105027,32,O
105027,(,O
105027,substantially,O
105027,different,O
105027,from,O
105027,normal,O
105027,values,O
105027,on,O
105027,[,O
105027,**9-14**,O
105027,],O
105027,),O
105027,.,O
105027,No,O
105027,blood,O
105027,or,O
105027,urine,O
105027,cultures,O
105027,were,O
105027,obtained,O
105027,.,O
105027,DIC,O
105027,labs,O
105027,were,O
105027,sent,O
105027,and,O
105027,revealed,O
105027,high,O
105027,fibrinogen,O
105027,",",O
105027,a,O
105027,mildly,O
105027,elevated,O
105027,INR,O
105027,",",O
105027,smear,O
105027,with,O
105027,occasional,O
105027,schistocytes,O
105027,.,O
105027,She,O
105027,was,O
105027,transferred,O
105027,to,O
105027,[,O
105027,**Hospital1,O
105027,18**,O
105027,],O
105027,for,O
105027,further,O
105027,management,O
105027,.,O
105027,In,O
105027,the,O
105027,[,O
105027,**Hospital1,O
105027,18**,O
105027,],O
105027,ED,O
105027,",",O
105027,her,O
105027,initial,O
105027,vitals,O
105027,were,O
105027,:,O
105027,100.4F,O
105027,",",O
105027,HR,O
105027,124,O
105027,",",O
105027,BP,O
105027,134/92,O
105027,",",O
105027,RR,O
105027,18,O
105027,",",O
105027,Sat,O
105027,99,O
105027,%,O
105027,(,O
105027,on,O
105027,room,O
105027,air,O
105027,),O
105027,.,O
105027,Repeat,O
105027,labs,O
105027,again,O
105027,demonstrated,O
105027,platelets,O
105027,of,O
105027,60K,O
105027,",",O
105027,stable,O
105027,hematocrit,O
105027,at,O
105027,31,O
105027,",",O
105027,elevated,O
105027,D-dimer,O
105027,",",O
105027,fibrinogen,O
105027,pending,O
105027,.,O
105027,Also,O
105027,apparently,O
105027,with,O
105027,new,O
105027,decrease,O
105027,in,O
105027,renal,O
105027,function,O
105027,.,O
105027,Heme-onc,O
105027,was,O
105027,called,O
105027,and,O
105027,advised,O
105027,to,O
105027,wait,O
105027,on,O
105027,anticoagulation,O
105027,;,O
105027,they,O
105027,would,O
105027,see,O
105027,the,O
105027,patient,O
105027,in,O
105027,the,O
105027,ICU,O
105027,.,O
105027,Clinically,O
105027,",",O
105027,she,O
105027,looks,O
105027,well,O
105027,except,O
105027,for,O
105027,back,B-Reason
105027,pain,I-Reason
105027,",",I-Reason
105027,which,O
105027,has,O
105027,been,O
105027,responding,O
105027,to,O
105027,hydromorphone,B-Drug
105027,.,I-Drug
105027,Vitals,O
105027,prior,O
105027,to,O
105027,transfer,O
105027,are,O
105027,:,O
105027,145/90,O
105027,100,O
105027,18,O
105027,98RA,O
105027,.,O
105027,In,O
105027,the,O
105027,ED,O
105027,she,O
105027,received,O
105027,3L,B-Dosage
105027,NS,O
105027,",",O
105027,Piperacillin/Tazobactam,B-Drug
105027,4.5,O
105027,gm,O
105027,IV,O
105027,",",O
105027,vancomycin,B-Drug
105027,1gm,O
105027,IV,O
105027,",",O
105027,hydromorphone,B-Drug
105027,",",I-Drug
105027,and,O
105027,acetaminophen,B-Drug
105027,1gm,O
105027,.,O
105027,Review,O
105027,of,O
105027,systems,O
105027,:,O
105027,+,O
105027,chronic,O
105027,headaches,O
105027,with,O
105027,new,O
105027,frontal,O
105027,headaches,O
105027,for,O
105027,four,O
105027,days,O
105027,.,O
105027,No,O
105027,vision,O
105027,or,O
105027,hearing,O
105027,change,O
105027,.,O
105027,No,O
105027,URI,O
105027,symptoms,O
105027,.,O
105027,No,O
105027,N/V,O
105027,or,O
105027,diarrhea,O
105027,.,O
105027,No,O
105027,blood,O
105027,in,O
105027,stool,O
105027,.,O
105027,No,O
105027,constipation,O
105027,.,O
105027,Mild,O
105027,urinary,O
105027,urgency,O
105027,on,O
105027,friday,O
105027,",",O
105027,no,O
105027,dysuria,O
105027,",",O
105027,or,O
105027,hematuria,O
105027,.,O
105027,Mild,O
105027,ankle,O
105027,swelling,O
105027,s/p,O
105027,sprain,O
105027,.,O
105027,No,O
105027,weakness,O
105027,.,O
105027,``,O
105027,razor,O
105027,burn,O
105027,on,O
105027,legs,O
105027,'',O
105027,Pt,O
105027,reports,O
105027,easy,O
105027,bruising,O
105027,.,O
105027,H/o,O
105027,bleeding,O
105027,with,O
105027,TAH,O
105027,requiring,O
105027,repeat,O
105027,operation,O
105027,for,O
105027,internal,O
105027,bleeding,O
105027,.,O
105027,No,O
105027,h/o,O
105027,of,O
105027,bleeding,O
105027,with,O
105027,dental,O
105027,work,O
105027,.,O
105027,no,O
105027,history,O
105027,of,O
105027,clots,O
105027,.,O
105027,Past,O
105027,Medical,O
105027,History,O
105027,:,O
105027,-melanoma,O
105027,in,O
105027,situ,O
105027,excised,O
105027,11,O
105027,years,O
105027,prior,O
105027,to,O
105027,presentation,O
105027,",",O
105027,no,O
105027,recurrence,O
105027,-endometriosis,O
105027,-migraines,O
105027,-R,O
105027,radial,O
105027,nerve,O
105027,damage,O
105027,from,O
105027,compression,O
105027,-s/p,O
105027,TAH/USO,O
105027,8,O
105027,yrs,O
105027,ago,O
105027,",",O
105027,c/b,O
105027,need,O
105027,for,O
105027,3,B-Dosage
105027,units,I-Dosage
105027,PRBC,O
105027,due,O
105027,to,O
105027,bleeding,O
105027,at,O
105027,a,O
105027,ligation,O
105027,site,O
105027,-chronic,O
105027,anemia,O
105027,Social,O
105027,History,O
105027,:,O
105027,She,O
105027,is,O
105027,currently,O
105027,unemployed,O
105027,.,O
105027,She,O
105027,smokes,O
105027,1,O
105027,PPD,O
105027,since,O
105027,a,O
105027,teenage,O
105027,",",O
105027,and,O
105027,drinks,O
105027,socially,O
105027,.,O
105027,She,O
105027,is,O
105027,here,O
105027,alone,O
105027,",",O
105027,and,O
105027,denies,O
105027,any,O
105027,recent,O
105027,travel,O
105027,or,O
105027,insect/tick,O
105027,bites,O
105027,.,O
105027,Family,O
105027,History,O
105027,:,O
105027,Father,O
105027,has,O
105027,history,O
105027,of,O
105027,mesenteric,O
105027,vein,O
105027,thrombosis,O
105027,s/p,O
105027,small,O
105027,intestine,O
105027,resection,O
105027,;,O
105027,with,O
105027,h/o,O
105027,factor,O
105027,V,O
105027,leiden,O
105027,with,O
105027,unknown,O
105027,genetic,O
105027,profile,O
105027,.,O
105027,No,O
105027,further,O
105027,history,O
105027,of,O
105027,clotting,O
105027,or,O
105027,bleeding,O
105027,disorders,O
105027,in,O
105027,family,O
105027,.,O
105027,Physical,O
105027,Exam,O
105027,:,O
105027,GENERAL,O
105027,:,O
105027,Pleasant,O
105027,",",O
105027,young,O
105027,white,O
105027,female,O
105027,in,O
105027,moderate,O
105027,distress,O
105027,HEENT,O
105027,:,O
105027,Normocephalic,O
105027,",",O
105027,atraumatic,O
105027,.,O
105027,No,O
105027,conjunctival,O
105027,pallor,O
105027,.,O
105027,No,O
105027,scleral,O
105027,icterus,O
105027,.,O
105027,PERRLA/EOMI,O
105027,.,O
105027,Dry,O
105027,MM,O
105027,.,O
105027,OP,O
105027,clear,O
105027,.,O
105027,Neck,O
105027,Supple,O
105027,",",O
105027,No,O
105027,LAD,O
105027,",",O
105027,No,O
105027,thyromegaly,O
105027,.,O
105027,CARDIAC,O
105027,:,O
105027,Regular,O
105027,rhythm,O
105027,",",O
105027,tachycardic,O
105027,.,O
105027,Normal,O
105027,S1,O
105027,",",O
105027,S2,O
105027,.,O
105027,1/6,O
105027,SEM,O
105027,in,O
105027,LUSB,O
105027,no,O
105027,rubs,O
105027,or,O
105027,[,O
105027,**Last,O
105027,Name,O
105027,(,O
105027,un,O
105027,),O
105027,549**,O
105027,],O
105027,.,O
105027,JVP=,O
105027,2,O
105027,cm,O
105027,above,O
105027,clavicle,O
105027,.,O
105027,LUNGS,O
105027,:,O
105027,crackles,O
105027,R,O
105027,>,O
105027,L,O
105027,base,O
105027,",",O
105027,good,O
105027,air,O
105027,movement,O
105027,biaterally,O
105027,.,O
105027,ABDOMEN,O
105027,:,O
105027,NABS,O
105027,.,O
105027,Soft,O
105027,",",O
105027,ND,O
105027,.,O
105027,BL,O
105027,upper,O
105027,quad,O
105027,tenderness,O
105027,",",O
105027,greatest,O
105027,in,O
105027,RUQ,O
105027,.,O
105027,gaurding,O
105027,in,O
105027,RUQ,O
105027,without,O
105027,rebound,O
105027,.,O
105027,No,O
105027,HSM,O
105027,Left,O
105027,CVA,O
105027,tenderness,O
105027,.,O
105027,EXTREMITIES,O
105027,:,O
105027,No,O
105027,edema,O
105027,or,O
105027,calf,O
105027,pain,O
105027,",",O
105027,2+,O
105027,dorsalis,O
105027,pedis/,O
105027,posterior,O
105027,tibial,O
105027,pulses,O
105027,.,O
105027,SKIN,O
105027,:,O
105027,1mm,O
105027,erthyematous,O
105027,macules,O
105027,at,O
105027,sites,O
105027,of,O
105027,follicules,O
105027,on,O
105027,BL,O
105027,shins,O
105027,.,O
105027,No,O
105027,ecchymoses,O
105027,.,O
105027,NEURO,O
105027,:,O
105027,A,O
105027,&,O
105027,Ox3,O
105027,.,O
105027,Appropriate,O
105027,.,O
105027,CN,O
105027,2-12,O
105027,grossly,O
105027,intact,O
105027,.,O
105027,Preserved,O
105027,sensation,O
105027,throughout,O
105027,.,O
105027,5/5,O
105027,strength,O
105027,throughout,O
105027,except,O
105027,[,O
105027,**2-1**,O
105027,],O
105027,with,O
105027,left,O
105027,hand,O
105027,grip,O
105027,.,O
105027,[,O
105027,**12-1**,O
105027,],O
105027,+,O
105027,reflexes,O
105027,",",O
105027,equal,O
105027,BL,O
105027,.,O
105027,Gait,O
105027,assessment,O
105027,deferred,O
105027,.,O
105027,NL,O
105027,coordination,O
105027,.,O
105027,PSYCH,O
105027,:,O
105027,Listens,O
105027,and,O
105027,responds,O
105027,to,O
105027,questions,O
105027,appropriately,O
105027,",",O
105027,pleasant,O
105027,Pertinent,O
105027,Results,O
105027,:,O
105027,===================,O
105027,LABORATORY,O
105027,RESULTS,O
105027,===================,O
105027,On,O
105027,Admission,O
105027,:,O
105027,WBC-3.7*,O
105027,RBC-2.98*,O
105027,Hgb-10.4*,O
105027,Hct-31.2*,O
105027,MCV-105*,O
105027,RDW-14.6,O
105027,Plt,O
105027,Ct-60*,O
105027,Na,O
105027,138,O
105027,",",O
105027,K,O
105027,3*,O
105027,",",O
105027,Cl,O
105027,109*,O
105027,",",O
105027,HCO3*,O
105027,BUN,O
105027,21*,O
105027,",",O
105027,Cr,O
105027,1.2*,O
105027,",",O
105027,Glu,O
105027,92,O
105027,PT-13.5*,O
105027,PTT-25.5,O
105027,INR,O
105027,(,O
105027,PT,O
105027,),O
105027,-1.2*,O
105027,ALT-25,O
105027,AST-24,O
105027,LD,O
105027,(,O
105027,LDH,O
105027,),O
105027,-466*,O
105027,AlkPhos-104,O
105027,TotBili-0.4,O
105027,On,O
105027,Discharge,O
105027,:,O
105027,WBC-12.2*,O
105027,RBC-3.04*,O
105027,#,O
105027,Hgb-9.2*,O
105027,#,O
105027,Hct-29.0*,O
105027,#,O
105027,MCV-95,O
105027,RDW-17.8*,O
105027,Plt,O
105027,Ct-183,O
105027,19.3*,O
105027,PTT-31.8,O
105027,INR,O
105027,(,O
105027,PT,O
105027,),O
105027,-1.8*,O
105027,Other,O
105027,Important,O
105027,Labs,O
105027,:,O
105027,Lupus-NEG,O
105027,ACA,O
105027,IgG-11.4,O
105027,ACA,O
105027,IgM-16.6*,O
105027,AT,O
105027,III-70,O
105027,ANCA-NEGATIVE,O
105027,B,O
105027,RheuFac-65*,O
105027,C3-89*,O
105027,C4-8*,O
105027,HIV,O
105027,Ab-NEGATIVE,O
105027,FACTOR,O
105027,V,O
105027,LEIDEN-Test,O
105027,negative,O
105027,=============,O
105027,MICROBIOLOGY,O
105027,=============,O
105027,Blood,O
105027,Cultures*23,O
105027,:,O
105027,No,O
105027,Growth,O
105027,To,O
105027,Date,O
105027,Urine,O
105027,Culture,O
105027,*,O
105027,9,O
105027,:,O
105027,No,O
105027,Growth,O
105027,To,O
105027,Date,O
105027,===============================,O
105027,Radiology,O
105027,AND,O
105027,OTHER,O
105027,STRATEGIES,O
105027,===============================,O
105027,ECG,O
105027,[,O
105027,**2125-9-18**,O
105027,],O
105027,:,O
105027,Sinus,O
105027,tachycardia,O
105027,.,O
105027,Poor,O
105027,R,O
105027,wave,O
105027,progression,O
105027,is,O
105027,probably,O
105027,a,O
105027,normal,O
105027,variant,O
105027,.,O
105027,Diffuse,O
105027,T,O
105027,wave,O
105027,changes,O
105027,that,O
105027,are,O
105027,non-specific,O
105027,.,O
105027,No,O
105027,previous,O
105027,tracing,O
105027,available,O
105027,for,O
105027,comparison,O
105027,.,O
105027,Chest,O
105027,Radiograph,O
105027,[,O
105027,**2125-9-18**,O
105027,],O
105027,:,O
105027,IMPRESSION,O
105027,:,O
105027,Mild,O
105027,interstitial,O
105027,edema,O
105027,.,O
105027,Small,O
105027,left,O
105027,effusion,O
105027,.,O
105027,Ultrasound,O
105027,of,O
105027,Abdomen,O
105027,[,O
105027,**2125-9-18**,O
105027,],O
105027,:,O
105027,IMPRESSION,O
105027,:,O
105027,1,O
105027,.,O
105027,Enlarged,O
105027,and,O
105027,heterogeneous,O
105027,left,O
105027,kidney,O
105027,",",O
105027,consistent,O
105027,with,O
105027,given,O
105027,history,O
105027,of,O
105027,pyelonephritis,O
105027,",",O
105027,with,O
105027,a,O
105027,number,O
105027,of,O
105027,hypoechoic,O
105027,areas,O
105027,in,O
105027,the,O
105027,upper,O
105027,pole,O
105027,potentially,O
105027,suspicious,O
105027,for,O
105027,abscess,O
105027,.,O
105027,No,O
105027,evidence,O
105027,of,O
105027,hydronephrosis,O
105027,.,O
105027,2,O
105027,.,O
105027,Nondistended,O
105027,gallbladder,O
105027,with,O
105027,gallbladder,O
105027,wall,O
105027,edema,O
105027,likely,O
105027,secondary,O
105027,to,O
105027,third,O
105027,spacing,O
105027,.,O
105027,No,O
105027,specific,O
105027,son,O
105027,[,O
105027,**Name,O
105027,(,O
105027,NI,O
105027,),O
105027,493**,O
105027,],O
105027,evidence,O
105027,for,O
105027,cholecystitis,O
105027,.,O
105027,3,O
105027,.,O
105027,The,O
105027,CBD,O
105027,is,O
105027,dilated,O
105027,measuring,O
105027,0.8,O
105027,cm,O
105027,without,O
105027,intrahepatic,O
105027,bile,O
105027,dilatation,O
105027,.,O
105027,4,O
105027,.,O
105027,Patent,O
105027,portal,O
105027,vein,O
105027,.,O
105027,CT,O
105027,Abdomen,O
105027,and,O
105027,Pelvis,O
105027,W/Contrast,O
105027,[,O
105027,**2125-9-18**,O
105027,],O
105027,:,O
105027,IMPRESSION,O
105027,:,O
105027,1,O
105027,.,O
105027,Severe,O
105027,acute,O
105027,left,O
105027,pyelonephritis,O
105027,with,O
105027,marked,O
105027,renal,O
105027,edema,O
105027,",",O
105027,evolving,O
105027,foci,O
105027,of,O
105027,hypoperfusion,O
105027,",",O
105027,parenchymal,O
105027,necrosis,O
105027,",",O
105027,inflammatory,O
105027,phlegmon,O
105027,or,O
105027,early,O
105027,abscess,O
105027,formation,O
105027,.,O
105027,2,O
105027,.,O
105027,Multiple,O
105027,pulmonary,O
105027,nodules,O
105027,measuring,O
105027,up,O
105027,to,O
105027,4,O
105027,mm,O
105027,in,O
105027,the,O
105027,left,O
105027,lower,O
105027,lobe,O
105027,.,O
105027,In,O
105027,the,O
105027,setting,O
105027,of,O
105027,infection,O
105027,",",O
105027,these,O
105027,could,O
105027,reflect,O
105027,septic,O
105027,emboli,O
105027,or,O
105027,other,O
105027,infectious,O
105027,processes,O
105027,.,O
105027,Followup,O
105027,chest,O
105027,CT,O
105027,to,O
105027,document,O
105027,resolution,O
105027,is,O
105027,recommended,O
105027,.,O
105027,3,O
105027,.,O
105027,Bilateral,O
105027,pleural,O
105027,effusions,O
105027,and,O
105027,basilar,O
105027,consolidations,O
105027,could,O
105027,reflect,O
105027,atelectasis,O
105027,and/or,O
105027,superimposed,O
105027,pneumonia,O
105027,.,O
105027,4,O
105027,.,O
105027,Gallbladder,O
105027,wall,O
105027,edema,O
105027,",",O
105027,pericholecystic,O
105027,fluid,O
105027,and,O
105027,pericholecystic,O
105027,hepatic,O
105027,parenchymal,O
105027,hyperemia,O
105027,",",O
105027,unchanged,O
105027,from,O
105027,prior,O
105027,ultrasound,O
105027,.,O
105027,While,O
105027,these,O
105027,findings,O
105027,are,O
105027,felt,O
105027,likely,O
105027,reactive,O
105027,in,O
105027,the,O
105027,setting,O
105027,of,O
105027,other,O
105027,abnormalities,O
105027,(,O
105027,particularly,O
105027,since,O
105027,the,O
105027,gallbladder,O
105027,does,O
105027,not,O
105027,appear,O
105027,distended,O
105027,),O
105027,",",O
105027,by,O
105027,imaging,O
105027,this,O
105027,is,O
105027,equivocal,O
105027,for,O
105027,acute,O
105027,cholecystitis,O
105027,",",O
105027,and,O
105027,therefore,O
105027,if,O
105027,there,O
105027,is,O
105027,clinical,O
105027,concern,O
105027,a,O
105027,HIDA,O
105027,scan,O
105027,may,O
105027,be,O
105027,considered,O
105027,.,O
105027,MRI,O
105027,Abdomen,O
105027,W,O
105027,and,O
105027,W/O,O
105027,Contrast,O
105027,[,O
105027,**2125-9-18**,O
105027,],O
105027,:,O
105027,IMPRESSION,O
105027,:,O
105027,1,O
105027,.,O
105027,Acute,O
105027,infarction,O
105027,involving,O
105027,much,O
105027,of,O
105027,the,O
105027,upper,O
105027,pole,O
105027,and,O
105027,interpolar,O
105027,region,O
105027,of,O
105027,the,O
105027,left,O
105027,kidney,O
105027,",",O
105027,coexistent,O
105027,pyelonephritis,O
105027,is,O
105027,possible,O
105027,.,O
105027,Two,O
105027,small,O
105027,discrete,O
105027,regions,O
105027,of,O
105027,fluid,O
105027,signal,O
105027,intensity,O
105027,may,O
105027,be,O
105027,explained,O
105027,by,O
105027,necrosis,O
105027,",",O
105027,although,O
105027,abscess,O
105027,formation,O
105027,can,O
105027,not,O
105027,be,O
105027,excluded,O
105027,.,O
105027,2,O
105027,.,O
105027,Irregularity,O
105027,of,O
105027,bilateral,O
105027,renal,O
105027,arteries,O
105027,though,O
105027,confidence,O
105027,in,O
105027,that,O
105027,finding,O
105027,is,O
105027,low,O
105027,due,O
105027,to,O
105027,motion,O
105027,and,O
105027,potential,O
105027,artifact,O
105027,-,O
105027,fibromuscular,O
105027,dysplasia,O
105027,or,O
105027,vasculitis,O
105027,can,O
105027,have,O
105027,this,O
105027,appearance,O
105027,.,O
105027,A,O
105027,repeat,O
105027,study,O
105027,of,O
105027,the,O
105027,renal,O
105027,arteries,O
105027,is,O
105027,suggested,O
105027,when,O
105027,the,O
105027,patient,O
105027,is,O
105027,more,O
105027,stable,O
105027,.,O
105027,3,O
105027,.,O
105027,Gallbladder,O
105027,wall,O
105027,edema,O
105027,is,O
105027,commonly,O
105027,seen,O
105027,with,O
105027,third,O
105027,spacing,O
105027,of,O
105027,fluid,O
105027,.,O
105027,Common,O
105027,bile,O
105027,duct,O
105027,dilated,O
105027,to,O
105027,9,O
105027,mm,O
105027,",",O
105027,but,O
105027,has,O
105027,normal,O
105027,distal,O
105027,smooth,O
105027,tapering,O
105027,and,O
105027,there,O
105027,is,O
105027,no,O
105027,evidence,O
105027,of,O
105027,cholelithiasis,O
105027,or,O
105027,choledocholithiasis,O
105027,.,O
105027,4,O
105027,.,O
105027,Small,O
105027,bilateral,O
105027,pleural,O
105027,effusions,O
105027,and,O
105027,atelectasis,O
105027,and/or,O
105027,consolidation,O
105027,at,O
105027,the,O
105027,lung,O
105027,bases,O
105027,.,O
105027,CT,O
105027,Chest,O
105027,W/O,O
105027,Contrast,O
105027,[,O
105027,**2125-9-22**,O
105027,],O
105027,:,O
105027,IMPRESSION,O
105027,:,O
105027,1,O
105027,.,O
105027,Diffuse,O
105027,ground-glass,O
105027,opacity,O
105027,primarily,O
105027,within,O
105027,the,O
105027,bilateral,O
105027,upper,O
105027,lobes,O
105027,.,O
105027,Differential,O
105027,diagnosis,O
105027,includes,O
105027,atypical,O
105027,infectious,O
105027,pneumonia,O
105027,",",O
105027,such,O
105027,as,O
105027,PCP,O
105027,",",O
105027,[,O
105027,**Name10,O
105027,(,O
105027,NameIs,O
105027,),O
105027,84655**,O
105027,],O
105027,pneumonia,O
105027,and,O
105027,pulmonary,O
105027,edema/hemorrhage,O
105027,.,O
105027,2,O
105027,.,O
105027,Bilateral,O
105027,pleural,O
105027,effusions,O
105027,",",O
105027,left,O
105027,greater,O
105027,than,O
105027,right,O
105027,.,O
105027,3,O
105027,.,O
105027,Emphysematous,O
105027,changes,O
105027,.,O
105027,TTE,O
105027,[,O
105027,**2125-9-24**,O
105027,],O
105027,:,O
105027,Conclusions,O
105027,No,O
105027,thrombus/mass,O
105027,is,O
105027,seen,O
105027,in,O
105027,the,O
105027,body,O
105027,of,O
105027,the,O
105027,left,O
105027,atrium,O
105027,.,O
105027,A,O
105027,patent,O
105027,foramen,O
105027,ovale,O
105027,is,O
105027,present,O
105027,.,O
105027,Left,O
105027,ventricular,O
105027,wall,O
105027,thickness,O
105027,",",O
105027,cavity,O
105027,size,O
105027,",",O
105027,and,O
105027,global,O
105027,systolic,O
105027,function,O
105027,are,O
105027,normal,O
105027,(,O
105027,LVEF,O
105027,>,O
105027,55,O
105027,%,O
105027,),O
105027,.,O
105027,No,O
105027,masses,O
105027,or,O
105027,thrombi,O
105027,are,O
105027,seen,O
105027,in,O
105027,the,O
105027,left,O
105027,ventricle,O
105027,.,O
105027,Right,O
105027,ventricular,O
105027,chamber,O
105027,size,O
105027,and,O
105027,free,O
105027,wall,O
105027,motion,O
105027,are,O
105027,normal,O
105027,.,O
105027,The,O
105027,aortic,O
105027,valve,O
105027,leaflets,O
105027,(,O
105027,3,O
105027,),O
105027,appear,O
105027,structurally,O
105027,normal,O
105027,with,O
105027,good,O
105027,leaflet,O
105027,excursion,O
105027,and,O
105027,no,O
105027,aortic,O
105027,regurgitation,O
105027,.,O
105027,No,O
105027,masses,O
105027,or,O
105027,vegetations,O
105027,are,O
105027,seen,O
105027,on,O
105027,the,O
105027,aortic,O
105027,valve,O
105027,.,O
105027,The,O
105027,mitral,O
105027,valve,O
105027,appears,O
105027,structurally,O
105027,normal,O
105027,with,O
105027,trivial,O
105027,mitral,O
105027,regurgitation,O
105027,.,O
105027,There,O
105027,is,O
105027,no,O
105027,mitral,O
105027,valve,O
105027,prolapse,O
105027,.,O
105027,No,O
105027,mass,O
105027,or,O
105027,vegetation,O
105027,is,O
105027,seen,O
105027,on,O
105027,the,O
105027,mitral,O
105027,valve,O
105027,.,O
105027,The,O
105027,pulmonary,O
105027,artery,O
105027,systolic,O
105027,pressure,O
105027,could,O
105027,not,O
105027,be,O
105027,determined,O
105027,.,O
105027,There,O
105027,is,O
105027,a,O
105027,trivial/physiologic,O
105027,pericardial,O
105027,effusion,O
105027,.,O
105027,Compared,O
105027,with,O
105027,the,O
105027,prior,O
105027,study,O
105027,(,O
105027,images,O
105027,reviewed,O
105027,),O
105027,of,O
105027,[,O
105027,**2125-9-18**,O
105027,],O
105027,",",O
105027,a,O
105027,patent,O
105027,foramen,O
105027,ovale,O
105027,is,O
105027,seen,O
105027,.,O
105027,MRA,O
105027,Kidney,O
105027,W/,O
105027,and,O
105027,W/O,O
105027,Contrast,O
105027,[,O
105027,**2125-9-24**,O
105027,],O
105027,:,O
105027,IMPRESSION,O
105027,:,O
105027,1,O
105027,.,O
105027,Enlarged,O
105027,left,O
105027,kidney,O
105027,",",O
105027,with,O
105027,large,O
105027,",",O
105027,wedge-shaped,O
105027,areas,O
105027,of,O
105027,liquefactive,O
105027,necrosis,O
105027,at,O
105027,the,O
105027,upper,O
105027,pole,O
105027,and,O
105027,interpolar,O
105027,region,O
105027,.,O
105027,The,O
105027,areas,O
105027,of,O
105027,involvement,O
105027,are,O
105027,unchanged,O
105027,in,O
105027,size,O
105027,and,O
105027,appearance,O
105027,.,O
105027,While,O
105027,abscesses,O
105027,can,O
105027,not,O
105027,be,O
105027,completely,O
105027,excluded,O
105027,",",O
105027,the,O
105027,presence,O
105027,of,O
105027,preserved,O
105027,capsular,O
105027,enhancement,O
105027,",",O
105027,and,O
105027,the,O
105027,absence,O
105027,of,O
105027,extensive,O
105027,edema,O
105027,or,O
105027,perinephric,O
105027,inflammatory,O
105027,changes,O
105027,is,O
105027,more,O
105027,consistent,O
105027,with,O
105027,multifocal,O
105027,infarct,O
105027,.,O
105027,Given,O
105027,the,O
105027,clinical,O
105027,presentation,O
105027,",",O
105027,MR,O
105027,findings,O
105027,are,O
105027,most,O
105027,consistent,O
105027,with,O
105027,multiple,O
105027,renal,O
105027,infarcts,O
105027,in,O
105027,the,O
105027,setting,O
105027,of,O
105027,pyelonephritis,O
105027,.,O
105027,2,O
105027,.,O
105027,Normal,O
105027,renal,O
105027,vasculature,O
105027,",",O
105027,with,O
105027,no,O
105027,abnormalities,O
105027,of,O
105027,the,O
105027,renal,O
105027,arteries,O
105027,to,O
105027,suggest,O
105027,fibromuscular,O
105027,dysplasia,O
105027,or,O
105027,vasculitis,O
105027,.,O
105027,Widely,O
105027,patent,O
105027,left,O
105027,renal,O
105027,vein,O
105027,without,O
105027,filling,O
105027,defect,O
105027,.,O
105027,3,O
105027,.,O
105027,Moderate,O
105027,left,O
105027,and,O
105027,small,O
105027,right,O
105027,pleural,O
105027,effusions,O
105027,with,O
105027,atelectasis,O
105027,.,O
105027,Bilateral,O
105027,Lower,O
105027,Extremity,O
105027,Ultrasounds,O
105027,[,O
105027,**2125-9-25**,O
105027,],O
105027,:,O
105027,IMPRESSION,O
105027,:,O
105027,1,O
105027,.,O
105027,No,O
105027,evidence,O
105027,of,O
105027,DVT,O
105027,in,O
105027,the,O
105027,lower,O
105027,extremities,O
105027,.,O
105027,CTA,O
105027,Chest,O
105027,W/,O
105027,and,O
105027,W/O,O
105027,Contrast,O
105027,[,O
105027,**2125-9-26**,O
105027,],O
105027,:,O
105027,IMPRESSION,O
105027,:,O
105027,1,O
105027,.,O
105027,No,O
105027,pulmonary,O
105027,embolus,O
105027,.,O
105027,No,O
105027,aortic,O
105027,dissection,O
105027,.,O
105027,2,O
105027,.,O
105027,Resolved,O
105027,right,O
105027,pleural,O
105027,effusion,O
105027,and,O
105027,persistent,O
105027,but,O
105027,now,O
105027,slightly,O
105027,loculated,O
105027,moderate,O
105027,left,O
105027,pleural,O
105027,effusion,O
105027,with,O
105027,associated,O
105027,atelectasis,O
105027,.,O
105027,3,O
105027,.,O
105027,Decreased,O
105027,ground-glass,O
105027,opacification,O
105027,in,O
105027,the,O
105027,background,O
105027,of,O
105027,persistent,O
105027,emphysema,O
105027,.,O
105027,4,O
105027,.,O
105027,Incompletely,O
105027,characterized,O
105027,right,O
105027,kidney,O
105027,abnormality,O
105027,RUQ,O
105027,Ultrasound,O
105027,[,O
105027,**2125-9-28**,O
105027,],O
105027,:,O
105027,IMPRESSION,O
105027,:,O
105027,1,O
105027,.,O
105027,Non-distended,O
105027,gallbladder,O
105027,",",O
105027,with,O
105027,no,O
105027,pericholecystic,O
105027,fluid,O
105027,or,O
105027,cholelithiasis,O
105027,.,O
105027,No,O
105027,specific,O
105027,son,O
105027,[,O
105027,**Name,O
105027,(,O
105027,NI,O
105027,),O
105027,493**,O
105027,],O
105027,evidence,O
105027,for,O
105027,cholecystitis,O
105027,.,O
105027,2,O
105027,.,O
105027,Persistent,O
105027,dilatation,O
105027,of,O
105027,the,O
105027,common,O
105027,bile,O
105027,duct,O
105027,without,O
105027,intrahepatic,O
105027,bile,O
105027,duct,O
105027,dilatation,O
105027,.,O
105027,No,O
105027,son,O
105027,[,O
105027,**Name,O
105027,(,O
105027,NI,O
105027,),O
105027,493**,O
105027,],O
105027,evidence,O
105027,for,O
105027,choledocholithiasis,O
105027,within,O
105027,the,O
105027,visualized,O
105027,common,O
105027,duct,O
105027,.,O
105027,Chest,O
105027,Radiograph,O
105027,[,O
105027,**2125-10-2**,O
105027,],O
105027,:,O
105027,IMPRESSION,O
105027,:,O
105027,Small,O
105027,stable,O
105027,left,O
105027,pleural,O
105027,effusion,O
105027,",",O
105027,with,O
105027,no,O
105027,evidence,O
105027,of,O
105027,pneumothorax,O
105027,.,O
105027,MRI,O
105027,Abdomen,O
105027,W/,O
105027,and,O
105027,W/O,O
105027,Contrast,O
105027,[,O
105027,**2125-10-4**,O
105027,],O
105027,:,O
105027,IMPRESSION,O
105027,:,O
105027,1,O
105027,.,O
105027,No,O
105027,new,O
105027,areas,O
105027,of,O
105027,infarction,O
105027,within,O
105027,the,O
105027,left,O
105027,kidney,O
105027,compared,O
105027,to,O
105027,multiple,O
105027,prior,O
105027,studies,O
105027,.,O
105027,Areas,O
105027,of,O
105027,T2,O
105027,signal,O
105027,hyperintensity,O
105027,within,O
105027,the,O
105027,lateral,O
105027,interpolar,O
105027,region,O
105027,and,O
105027,upper,O
105027,pole,O
105027,of,O
105027,the,O
105027,left,O
105027,kidney,O
105027,corresponding,O
105027,to,O
105027,stable,O
105027,areas,O
105027,of,O
105027,absent,O
105027,contrast,O
105027,enhancement,O
105027,in,O
105027,addition,O
105027,to,O
105027,striated,O
105027,enhancement,O
105027,within,O
105027,the,O
105027,left,O
105027,lower,O
105027,pole,O
105027,.,O
105027,These,O
105027,findings,O
105027,represent,O
105027,features,O
105027,of,O
105027,both,O
105027,pyelonephritis,O
105027,and,O
105027,infarction,O
105027,.,O
105027,Small,O
105027,vessel,O
105027,vasculitis,O
105027,should,O
105027,be,O
105027,included,O
105027,in,O
105027,the,O
105027,differential,O
105027,.,O
105027,2,O
105027,.,O
105027,Resolution,O
105027,of,O
105027,right,O
105027,pleural,O
105027,effusion,O
105027,with,O
105027,decrease,O
105027,in,O
105027,size,O
105027,of,O
105027,small,O
105027,left,O
105027,pleural,O
105027,effusion,O
105027,.,O
105027,Brief,O
105027,Hospital,O
105027,Course,O
105027,:,O
105027,37,O
105027,year,O
105027,old,O
105027,female,O
105027,with,O
105027,acute,O
105027,onset,O
105027,thyrombocytopenia,O
105027,and,O
105027,sepsis,O
105027,likely,O
105027,secondary,O
105027,to,O
105027,renal,O
105027,infarction,O
105027,and,O
105027,pyelonephritis,O
105027,.,O
105027,1,O
105027,),O
105027,SIRS/Sepsis,B-Reason
105027,:,I-Reason
105027,Patient,O
105027,initially,O
105027,presented,O
105027,with,O
105027,left,O
105027,flank,O
105027,pain,O
105027,",",O
105027,tachycardia,O
105027,",",O
105027,low,O
105027,WBC,O
105027,",",O
105027,and,O
105027,low,O
105027,platelets,O
105027,.,O
105027,Based,O
105027,on,O
105027,OSH,O
105027,non-contrast,O
105027,CT,O
105027,scan,O
105027,it,O
105027,appeared,O
105027,this,O
105027,was,O
105027,consistent,O
105027,with,O
105027,pyelonephritis,O
105027,.,O
105027,She,O
105027,was,O
105027,started,O
105027,on,O
105027,cefepime,B-Drug
105027,",",I-Drug
105027,flagyl,O
105027,and,O
105027,vancomycin,B-Drug
105027,[,O
105027,**9-19**,O
105027,],O
105027,.,O
105027,With,O
105027,concern,O
105027,for,O
105027,worsening,O
105027,abdominal,O
105027,pain,O
105027,a,O
105027,repeat,O
105027,contrast,O
105027,abdominal,O
105027,and,O
105027,pelvic,O
105027,CT,O
105027,was,O
105027,performed,O
105027,.,O
105027,It,O
105027,showed,O
105027,severe,O
105027,acute,O
105027,left,O
105027,pyelonephritis,O
105027,with,O
105027,marked,O
105027,renal,O
105027,edema,O
105027,and,O
105027,evolving,O
105027,foci,O
105027,of,O
105027,hypoperfusion,O
105027,",",O
105027,parenchymal,O
105027,necrosis,O
105027,",",O
105027,inflammatory,O
105027,phlegmon,O
105027,or,O
105027,early,O
105027,abscess,O
105027,formation,O
105027,.,O
105027,Urology,O
105027,was,O
105027,consulted,O
105027,given,O
105027,concern,O
105027,for,O
105027,a,O
105027,need,O
105027,for,O
105027,acute,O
105027,surgical,O
105027,management,O
105027,.,O
105027,They,O
105027,suggested,O
105027,a,O
105027,concern,O
105027,for,O
105027,renal,O
105027,vein/artery,O
105027,thrombosis,O
105027,due,O
105027,to,O
105027,the,O
105027,appearance,O
105027,of,O
105027,multifocal,O
105027,necrosis,O
105027,in,O
105027,the,O
105027,kidney,O
105027,.,O
105027,MRI,O
105027,revealed,O
105027,no,O
105027,acute,O
105027,thrombosis,O
105027,but,O
105027,was,O
105027,suggestive,O
105027,of,O
105027,an,O
105027,acute,O
105027,infarction,O
105027,involving,O
105027,much,O
105027,of,O
105027,the,O
105027,upper,O
105027,pole,O
105027,and,O
105027,interpolar,O
105027,region,O
105027,of,O
105027,the,O
105027,left,O
105027,kidney,O
105027,without,O
105027,being,O
105027,able,O
105027,to,O
105027,rule,O
105027,out,O
105027,coexistent,O
105027,pyelonephritis,O
105027,.,O
105027,The,O
105027,patient,O
105027,'s,O
105027,white,B-Reason
105027,count,I-Reason
105027,eventually,I-Reason
105027,trended,I-Reason
105027,up,I-Reason
105027,from,O
105027,a,O
105027,nadir,O
105027,of,O
105027,2.5,O
105027,to,O
105027,the,O
105027,9,O
105027,'s,O
105027,and,O
105027,she,O
105027,was,O
105027,transitioned,O
105027,from,O
105027,cefepime,B-Drug
105027,",",I-Drug
105027,vancomycin,O
105027,",",O
105027,and,O
105027,metronidazole,B-Drug
105027,to,O
105027,oral,B-Route
105027,ciprofloxacin,O
105027,.,O
105027,All,O
105027,cultures,O
105027,remained,O
105027,negative,O
105027,but,O
105027,she,O
105027,did,O
105027,complete,O
105027,a,O
105027,fourteen,B-Duration
105027,day,I-Duration
105027,course,I-Duration
105027,of,O
105027,antibiotics,B-Drug
105027,for,O
105027,a,O
105027,suspected,O
105027,pyelonephritis,B-Reason
105027,.,I-Reason
105027,Vasculitis,O
105027,was,O
105027,also,O
105027,considered,O
105027,as,O
105027,an,O
105027,etiology,O
105027,for,O
105027,her,O
105027,SIRS,O
105027,but,O
105027,no,O
105027,clear,O
105027,evidence,O
105027,for,O
105027,a,O
105027,particular,O
105027,syndrome,O
105027,was,O
105027,found,O
105027,.,O
105027,Her,O
105027,blood,O
105027,pressures,O
105027,stabilized,O
105027,and,O
105027,she,O
105027,was,O
105027,completely,O
105027,hemodynamically,O
105027,stable,O
105027,for,O
105027,>,O
105027,1,O
105027,wk,O
105027,prior,O
105027,to,O
105027,discharge,O
105027,.,O
105027,She,O
105027,did,O
105027,remain,O
105027,febrile,O
105027,despite,O
105027,negative,O
105027,cultures,O
105027,",",O
105027,which,O
105027,was,O
105027,thought,O
105027,most,O
105027,likely,O
105027,due,O
105027,to,O
105027,inflammation,O
105027,secondary,O
105027,to,O
105027,her,O
105027,necrotic,O
105027,kidney,O
105027,.,O
105027,Prior,O
105027,to,O
105027,discharge,O
105027,her,O
105027,fever,O
105027,curve,O
105027,had,O
105027,been,O
105027,trending,O
105027,down,O
105027,and,O
105027,she,O
105027,did,O
105027,not,O
105027,become,O
105027,more,O
105027,febrile,O
105027,after,O
105027,antibiotics,O
105027,were,O
105027,stopped,O
105027,.,O
105027,Cultures,O
105027,similarly,O
105027,remained,O
105027,negative,O
105027,.,O
105027,Repeat,O
105027,MRI,O
105027,of,O
105027,kidney,O
105027,was,O
105027,obtained,O
105027,to,O
105027,look,O
105027,for,O
105027,an,O
105027,abscess,O
105027,or,O
105027,closed,O
105027,space,O
105027,infection,O
105027,and,O
105027,was,O
105027,negative,O
105027,.,O
105027,2,O
105027,),O
105027,Left,O
105027,renal,O
105027,infarcts,O
105027,:,O
105027,Given,O
105027,patient,O
105027,'s,O
105027,family,O
105027,history,O
105027,of,O
105027,factor,O
105027,V,O
105027,leiden,O
105027,mutation,O
105027,there,O
105027,was,O
105027,some,O
105027,concern,O
105027,that,O
105027,she,O
105027,could,O
105027,have,O
105027,a,O
105027,thrombophilia,O
105027,predisposing,O
105027,her,O
105027,to,O
105027,clot,O
105027,.,O
105027,Agitated,O
105027,saline,O
105027,TTE,O
105027,revealed,O
105027,a,O
105027,PFO,O
105027,",",O
105027,which,O
105027,raised,O
105027,concern,O
105027,for,O
105027,paradoxical,O
105027,embolization,O
105027,but,O
105027,work,O
105027,up,O
105027,for,O
105027,VTE,O
105027,was,O
105027,unremarkable,O
105027,.,O
105027,Severe,O
105027,pyelonephritis,O
105027,could,O
105027,also,O
105027,cause,O
105027,renal,O
105027,infarction,O
105027,but,O
105027,as,O
105027,reported,O
105027,above,O
105027,cultures,O
105027,never,O
105027,impressively,O
105027,reenforced,O
105027,a,O
105027,pyelonephritis,O
105027,.,O
105027,Similarly,O
105027,septic,O
105027,emboli,O
105027,were,O
105027,thought,O
105027,extremely,O
105027,unlikely,O
105027,given,O
105027,persistently,O
105027,negative,O
105027,blood,O
105027,cultures,O
105027,.,O
105027,Investigation,O
105027,for,O
105027,factor,O
105027,V,O
105027,leiden,O
105027,mutation,O
105027,was,O
105027,negative,O
105027,and,O
105027,no,O
105027,clear,O
105027,reason,O
105027,for,O
105027,hypercoagulability,O
105027,was,O
105027,found,O
105027,.,O
105027,The,O
105027,patient,O
105027,was,O
105027,nevertheless,O
105027,anticoagulated,O
105027,as,O
105027,the,O
105027,benefits,O
105027,of,O
105027,anticoagulation,B-Reason
105027,were,O
105027,felt,O
105027,to,O
105027,outweigh,O
105027,the,O
105027,risks,O
105027,.,O
105027,Therefore,O
105027,",",O
105027,she,O
105027,was,O
105027,started,O
105027,on,O
105027,coumadin,B-Drug
105027,and,O
105027,discharged,O
105027,on,O
105027,this,O
105027,as,O
105027,well,O
105027,as,O
105027,enoxaparin,B-Drug
105027,for,O
105027,bridge,O
105027,as,O
105027,she,O
105027,was,O
105027,not,O
105027,yet,O
105027,therapeutic,O
105027,.,O
105027,Renal,O
105027,function,O
105027,remained,O
105027,essentially,O
105027,stable,O
105027,after,O
105027,the,O
105027,patient,O
105027,was,O
105027,hydrated,O
105027,on,O
105027,her,O
105027,day,O
105027,of,O
105027,presentation,O
105027,.,O
105027,The,O
105027,patient,O
105027,will,O
105027,follow,O
105027,up,O
105027,in,O
105027,hematology,O
105027,for,O
105027,further,O
105027,hypercoagulability,O
105027,work-up,O
105027,.,O
105027,3,O
105027,),O
105027,Thrombocytopenia,O
105027,:,O
105027,The,O
105027,patient,O
105027,was,O
105027,transferred,O
105027,partially,O
105027,due,O
105027,to,O
105027,concern,O
105027,for,O
105027,DIC,O
105027,or,O
105027,TTP,O
105027,due,O
105027,to,O
105027,her,O
105027,thrombocytopenia,O
105027,.,O
105027,Hematology/Oncology,O
105027,was,O
105027,consulted,O
105027,and,O
105027,thought,O
105027,low,O
105027,platelets,O
105027,were,O
105027,not,O
105027,consistent,O
105027,with,O
105027,DIC,O
105027,or,O
105027,TTP,O
105027,and,O
105027,she,O
105027,did,O
105027,not,O
105027,have,O
105027,diagnostic,O
105027,numbers,O
105027,of,O
105027,schistocytes,O
105027,or,O
105027,a,O
105027,low,O
105027,fibrinogen,O
105027,.,O
105027,Most,O
105027,likely,O
105027,etiology,O
105027,of,O
105027,her,O
105027,thrombocytopenia,O
105027,was,O
105027,thought,O
105027,to,O
105027,be,O
105027,marrow,O
105027,suppression,O
105027,secondary,O
105027,to,O
105027,SIRS/sepsis,O
105027,.,O
105027,Ultimately,O
105027,her,O
105027,platelet,O
105027,count,O
105027,recovered,O
105027,and,O
105027,was,O
105027,normal,O
105027,at,O
105027,the,O
105027,time,O
105027,of,O
105027,discharge,O
105027,.,O
105027,She,O
105027,did,O
105027,receive,O
105027,one,O
105027,unit,O
105027,of,O
105027,platelets,O
105027,during,O
105027,an,O
105027,IJ,O
105027,placement,O
105027,.,O
105027,4,O
105027,),O
105027,Pulmonary,O
105027,edema/Pleural,O
105027,effusions,O
105027,:,O
105027,Initial,O
105027,CXR,O
105027,showed,O
105027,pulmonary,O
105027,edema,O
105027,with,O
105027,a,O
105027,small,O
105027,pleural,O
105027,effusion,O
105027,.,O
105027,A,O
105027,BNP,O
105027,was,O
105027,6587,O
105027,.,O
105027,An,O
105027,echocardiogram,O
105027,was,O
105027,performed,O
105027,with,O
105027,concern,O
105027,for,O
105027,cardiovascular,O
105027,compromise,O
105027,and,O
105027,it,O
105027,showed,O
105027,a,O
105027,normal,O
105027,ejection,O
105027,fraction,O
105027,",",O
105027,normal,O
105027,wall,O
105027,motion,O
105027,",",O
105027,and,O
105027,1+MR,O
105027,.,O
105027,It,O
105027,was,O
105027,felt,O
105027,the,O
105027,patient,O
105027,'s,O
105027,pulmonary,B-ADE
105027,edema,I-ADE
105027,and,I-ADE
105027,effusions,I-ADE
105027,were,O
105027,secondary,O
105027,to,O
105027,fluid,B-Drug
105027,resuscitation,O
105027,.,O
105027,She,O
105027,had,O
105027,one,O
105027,episode,O
105027,of,O
105027,desaturation,O
105027,to,O
105027,88,O
105027,%,O
105027,when,O
105027,she,O
105027,laid,O
105027,flat,O
105027,in,O
105027,her,O
105027,CT,O
105027,scan,O
105027,.,O
105027,She,O
105027,intermittently,O
105027,required,O
105027,2,O
105027,Liters,O
105027,NC,O
105027,for,O
105027,comfort,O
105027,.,O
105027,Her,O
105027,difficulty,O
105027,breathing,O
105027,was,O
105027,felt,O
105027,to,O
105027,be,O
105027,due,O
105027,to,O
105027,her,O
105027,abdominal,O
105027,pain,O
105027,causing,O
105027,pain,O
105027,upon,O
105027,deep,O
105027,inspiration,O
105027,and,O
105027,fluid,O
105027,overload,O
105027,.,O
105027,Her,O
105027,pain,O
105027,was,O
105027,controlled,O
105027,and,O
105027,patient,O
105027,was,O
105027,auto-diuresing,O
105027,>,O
105027,150cc/hr,O
105027,upon,O
105027,transfer,O
105027,to,O
105027,the,O
105027,floor,O
105027,.,O
105027,She,O
105027,continued,O
105027,to,O
105027,auto-diurese,O
105027,on,O
105027,the,O
105027,floor,O
105027,and,O
105027,eventually,O
105027,came,O
105027,off,O
105027,of,O
105027,oxygen,O
105027,entirely,O
105027,.,O
105027,Better,O
105027,pain,O
105027,control,O
105027,significantly,O
105027,improved,O
105027,her,O
105027,respiratory,O
105027,function,O
105027,and,O
105027,prior,O
105027,to,O
105027,discharge,O
105027,her,O
105027,pulmonary,O
105027,exam,O
105027,was,O
105027,normal,O
105027,and,O
105027,she,O
105027,was,O
105027,ambulating,O
105027,without,O
105027,desaturations,O
105027,.,O
105027,CT,O
105027,showed,O
105027,a,O
105027,persistent,O
105027,",",O
105027,loculated,O
105027,pleural,O
105027,effusion,O
105027,",",O
105027,and,O
105027,given,O
105027,persistent,O
105027,fevers,O
105027,",",O
105027,a,O
105027,thoracentesis,O
105027,was,O
105027,attempted,O
105027,but,O
105027,as,O
105027,the,O
105027,effusion,O
105027,was,O
105027,steadily,O
105027,decreasing,O
105027,in,O
105027,size,O
105027,interventional,O
105027,pulmonology,O
105027,and,O
105027,interventional,O
105027,radiology,O
105027,thought,O
105027,it,O
105027,was,O
105027,too,O
105027,small,O
105027,to,O
105027,drain,O
105027,safely,O
105027,.,O
105027,As,O
105027,it,O
105027,continued,O
105027,to,O
105027,decrease,O
105027,in,O
105027,size,O
105027,and,O
105027,the,O
105027,patient,O
105027,WBC,O
105027,count,O
105027,and,O
105027,fevers,O
105027,were,O
105027,down,O
105027,trending,O
105027,this,O
105027,was,O
105027,not,O
105027,pursued,O
105027,further,O
105027,.,O
105027,5,O
105027,),O
105027,Abdominal,B-Reason
105027,pain,I-Reason
105027,:,I-Reason
105027,This,O
105027,was,O
105027,initially,O
105027,controlled,O
105027,with,O
105027,morphine,B-Drug
105027,and,O
105027,morphine,B-Drug
105027,SR,I-Drug
105027,.,I-Drug
105027,She,O
105027,appeared,O
105027,to,O
105027,be,O
105027,very,O
105027,drowsy,B-ADE
105027,and,O
105027,her,O
105027,RR,B-ADE
105027,decreased,I-ADE
105027,on,O
105027,this,O
105027,regimen,O
105027,",",O
105027,so,O
105027,the,O
105027,ms,B-Drug
105027,contin,I-Drug
105027,was,O
105027,discontinued,O
105027,.,O
105027,She,O
105027,continued,O
105027,to,O
105027,have,O
105027,significant,O
105027,pain,B-Reason
105027,",",I-Reason
105027,so,O
105027,a,O
105027,morphine,B-Drug
105027,PCA,O
105027,",",O
105027,maximum,O
105027,dose,O
105027,of,O
105027,4,B-Strength
105027,mg/hr,I-Strength
105027,",",I-Strength
105027,that,O
105027,was,O
105027,started,O
105027,and,O
105027,the,O
105027,patient,O
105027,'s,O
105027,pain,O
105027,improved,O
105027,significantly,O
105027,.,O
105027,It,O
105027,was,O
105027,assessed,O
105027,that,O
105027,her,O
105027,pain,O
105027,was,O
105027,consistent,O
105027,with,O
105027,post-embolization,O
105027,syndrome,O
105027,",",O
105027,which,O
105027,includes,O
105027,fever,O
105027,",",O
105027,abdominal,O
105027,pain,O
105027,secondary,O
105027,to,O
105027,the,O
105027,clearance,O
105027,process,O
105027,of,O
105027,necrotic,O
105027,tissue,O
105027,.,O
105027,Eventually,O
105027,she,O
105027,was,O
105027,reestablished,O
105027,on,O
105027,a,O
105027,regimen,O
105027,of,O
105027,morphine,B-Drug
105027,SR,I-Drug
105027,",",I-Drug
105027,morphine,O
105027,IR,O
105027,",",O
105027,and,O
105027,gabapentin,B-Drug
105027,with,O
105027,good,O
105027,improvement,O
105027,in,O
105027,her,O
105027,pain,B-Reason
105027,.,I-Reason
105027,She,O
105027,will,O
105027,likely,O
105027,need,O
105027,these,O
105027,for,O
105027,the,O
105027,next,O
105027,few,O
105027,months,O
105027,as,O
105027,her,O
105027,body,O
105027,clears,O
105027,necrotic,O
105027,tissue,O
105027,from,O
105027,her,O
105027,kidney,O
105027,.,O
105027,6,O
105027,),O
105027,Persistent,O
105027,sinus,O
105027,tachycardia,O
105027,:,O
105027,The,O
105027,patient,O
105027,informs,O
105027,us,O
105027,that,O
105027,she,O
105027,has,O
105027,exhibited,O
105027,fast,O
105027,heart,O
105027,rates,O
105027,for,O
105027,years,O
105027,.,O
105027,The,O
105027,patient,O
105027,did,O
105027,not,O
105027,appear,O
105027,volume,O
105027,down,O
105027,as,O
105027,her,O
105027,CVP,O
105027,remained,O
105027,high,O
105027,.,O
105027,It,O
105027,was,O
105027,felt,O
105027,that,O
105027,the,O
105027,tachycardia,O
105027,was,O
105027,due,O
105027,to,O
105027,pain,O
105027,",",O
105027,fever,O
105027,and,O
105027,the,O
105027,overall,O
105027,stress,O
105027,response,O
105027,of,O
105027,sepsis,O
105027,.,O
105027,The,O
105027,tachycardia,O
105027,improved,O
105027,to,O
105027,the,O
105027,low,O
105027,100s,O
105027,after,O
105027,the,O
105027,administration,O
105027,of,O
105027,the,O
105027,PCA,O
105027,and,O
105027,remained,O
105027,there,O
105027,through,O
105027,the,O
105027,day,O
105027,of,O
105027,discharge,O
105027,.,O
105027,7,O
105027,),O
105027,GERD,B-Reason
105027,:,I-Reason
105027,PPI,O
105027,held,O
105027,in,O
105027,setting,O
105027,of,O
105027,decreased,O
105027,plts,O
105027,.,O
105027,Ranitidine,B-Drug
105027,[,O
105027,**Hospital1,O
105027,**,O
105027,],O
105027,started,O
105027,and,O
105027,then,O
105027,discontinued,O
105027,when,O
105027,platelet,O
105027,count,O
105027,recovered,O
105027,as,O
105027,it,O
105027,was,O
105027,thought,O
105027,this,O
105027,was,O
105027,no,O
105027,longer,O
105027,indicated,O
105027,.,O
105027,The,O
105027,patient,O
105027,had,O
105027,a,O
105027,PICC,O
105027,for,O
105027,IV,O
105027,access,O
105027,that,O
105027,was,O
105027,discontinued,O
105027,prior,O
105027,to,O
105027,discharge,O
105027,.,O
105027,She,O
105027,was,O
105027,tolerating,O
105027,a,O
105027,full,O
105027,diet,O
105027,prior,O
105027,to,O
105027,discharge,O
105027,.,O
105027,She,O
105027,was,O
105027,full,O
105027,code,O
105027,.,O
105027,Medications,O
105027,on,O
105027,Admission,O
105027,:,O
105027,Neurotin,B-Drug
105027,300,O
105027,qam,B-Frequency
105027,",",I-Frequency
105027,1500,O
105027,qpm,B-Frequency
105027,Protonix,O
105027,daily,B-Frequency
105027,Discharge,O
105027,Medications,O
105027,:,O
105027,1,O
105027,.,O
105027,Gabapentin,B-Drug
105027,300,O
105027,mg,O
105027,Capsule,B-Form
105027,Sig,O
105027,:,O
105027,One,B-Dosage
105027,(,I-Dosage
105027,1,I-Dosage
105027,),I-Dosage
105027,Capsule,O
105027,PO,B-Route
105027,Q12H,O
105027,(,O
105027,every,O
105027,12,O
105027,hours,O
105027,),O
105027,as,O
105027,needed,O
105027,for,O
105027,pain,B-Reason
105027,for,O
105027,1,O
105027,months,O
105027,.,O
105027,Disp,O
105027,:,O
105027,*60,O
105027,Capsule,O
105027,(,O
105027,s,O
105027,),O
105027,*,O
105027,Refills,O
105027,:,O
105027,*0*,O
105027,2,O
105027,.,O
105027,Morphine,B-Drug
105027,15,O
105027,mg,O
105027,Tablet,B-Form
105027,Sig,O
105027,:,O
105027,One,B-Dosage
105027,(,I-Dosage
105027,1,I-Dosage
105027,),I-Dosage
105027,Tablet,O
105027,PO,B-Route
105027,Q4H,O
105027,(,O
105027,every,O
105027,4,O
105027,hours,O
105027,),O
105027,as,O
105027,needed,O
105027,for,O
105027,pain,B-Reason
105027,for,O
105027,1,O
105027,months,O
105027,.,O
105027,Disp,O
105027,:,O
105027,*180,O
105027,Tablet,O
105027,(,O
105027,s,O
105027,),O
105027,*,O
105027,Refills,O
105027,:,O
105027,*0*,O
105027,3,O
105027,.,O
105027,Morphine,B-Drug
105027,30,O
105027,mg,O
105027,Tablet,B-Form
105027,Sustained,I-Form
105027,Release,I-Form
105027,Sig,O
105027,:,O
105027,One,B-Dosage
105027,(,I-Dosage
105027,1,I-Dosage
105027,),I-Dosage
105027,Tablet,O
105027,Sustained,O
105027,Release,O
105027,PO,B-Route
105027,Q8H,O
105027,(,O
105027,every,O
105027,8,O
105027,hours,O
105027,),O
105027,for,B-Duration
105027,1,I-Duration
105027,months,I-Duration
105027,.,I-Duration
105027,Disp,O
105027,:,O
105027,*90,O
105027,Tablet,O
105027,Sustained,O
105027,Release,O
105027,(,O
105027,s,O
105027,),O
105027,*,O
105027,Refills,O
105027,:,O
105027,*0*,O
105027,4,O
105027,.,O
105027,Enoxaparin,B-Drug
105027,60,O
105027,mg/0.6,O
105027,mL,O
105027,Syringe,B-Form
105027,Sig,O
105027,:,O
105027,One,B-Dosage
105027,(,I-Dosage
105027,1,I-Dosage
105027,),I-Dosage
105027,syringe,O
105027,Subcutaneous,B-Route
105027,Q12H,O
105027,(,O
105027,every,O
105027,12,O
105027,hours,O
105027,),O
105027,for,B-Duration
105027,1,I-Duration
105027,months,I-Duration
105027,.,I-Duration
105027,Disp,O
105027,:,O
105027,*60,O
105027,syringe*,O
105027,Refills,O
105027,:,O
105027,*0*,O
105027,5,O
105027,.,O
105027,Acetaminophen,B-Drug
105027,650,O
105027,mg,O
105027,Tablet,B-Form
105027,Sig,O
105027,:,O
105027,One,B-Dosage
105027,(,I-Dosage
105027,1,I-Dosage
105027,),I-Dosage
105027,Tablet,O
105027,PO,B-Route
105027,every,O
105027,six,O
105027,(,O
105027,6,O
105027,),O
105027,hours,O
105027,as,O
105027,needed,O
105027,for,O
105027,fever,B-Reason
105027,or,O
105027,pain,B-Reason
105027,.,I-Reason
105027,6,O
105027,.,O
105027,Docusate,B-Drug
105027,Sodium,I-Drug
105027,100,O
105027,mg,O
105027,Capsule,B-Form
105027,Sig,O
105027,:,O
105027,One,B-Dosage
105027,(,I-Dosage
105027,1,I-Dosage
105027,),I-Dosage
105027,Capsule,O
105027,PO,B-Route
105027,twice,O
105027,a,O
105027,day,O
105027,.,O
105027,7,O
105027,.,O
105027,Senna,B-Drug
105027,8.6,O
105027,mg,O
105027,Tablet,B-Form
105027,Sig,O
105027,:,O
105027,Two,B-Dosage
105027,(,I-Dosage
105027,2,I-Dosage
105027,),I-Dosage
105027,Tablet,O
105027,PO,B-Route
105027,twice,O
105027,a,O
105027,day,O
105027,as,O
105027,needed,O
105027,for,O
105027,constipation,B-Reason
105027,.,I-Reason
105027,8,O
105027,.,O
105027,Warfarin,B-Drug
105027,2,O
105027,mg,O
105027,Tablet,B-Form
105027,Sig,O
105027,:,O
105027,Two,B-Dosage
105027,(,I-Dosage
105027,2,I-Dosage
105027,),I-Dosage
105027,Tablet,O
105027,PO,B-Route
105027,Once,O
105027,Daily,O
105027,at,O
105027,4,O
105027,PM,O
105027,.,O
105027,Disp,O
105027,:,O
105027,*60,O
105027,Tablet,O
105027,(,O
105027,s,O
105027,),O
105027,*,O
105027,Refills,O
105027,:,O
105027,*2*,O
105027,Discharge,O
105027,Disposition,O
105027,:,O
105027,Home,O
105027,Discharge,O
105027,Diagnosis,O
105027,:,O
105027,Renal,O
105027,infarctions,O
105027,of,O
105027,unclear,O
105027,significance,O
105027,?,O
105027,Pyelonephritis,O
105027,Patent,O
105027,foramen,O
105027,ovale,O
105027,Pleural,O
105027,effusion,O
105027,Discharge,O
105027,Condition,O
105027,:,O
105027,stable,O
105027,Discharge,O
105027,Instructions,O
105027,:,O
105027,You,O
105027,were,O
105027,admitted,O
105027,to,O
105027,the,O
105027,hospital,O
105027,with,O
105027,back,O
105027,pain,O
105027,and,O
105027,were,O
105027,found,O
105027,to,O
105027,have,O
105027,had,O
105027,injuries,O
105027,due,O
105027,to,O
105027,poor,O
105027,blood,O
105027,flow,O
105027,to,O
105027,parts,O
105027,of,O
105027,your,O
105027,kidney,O
105027,.,O
105027,It,O
105027,is,O
105027,unclear,O
105027,exactly,O
105027,why,O
105027,this,O
105027,occurred,O
105027,but,O
105027,we,O
105027,suspect,O
105027,you,O
105027,may,O
105027,have,O
105027,some,O
105027,predisposition,O
105027,toward,O
105027,forming,B-Reason
105027,blood,I-Reason
105027,clots,I-Reason
105027,.,I-Reason
105027,Therefore,O
105027,",",O
105027,you,O
105027,have,O
105027,been,O
105027,started,O
105027,on,O
105027,blood,O
105027,thinners,O
105027,to,O
105027,prevent,O
105027,futher,O
105027,such,O
105027,events,O
105027,.,O
105027,You,O
105027,have,O
105027,been,O
105027,started,O
105027,on,O
105027,coumadin,B-Drug
105027,as,O
105027,a,O
105027,long,B-Reason
105027,term,I-Reason
105027,blood,I-Reason
105027,thinner,I-Reason
105027,",",I-Reason
105027,you,O
105027,are,O
105027,being,O
105027,discharged,O
105027,on,O
105027,enoxaparin,B-Drug
105027,",",I-Drug
105027,a,O
105027,blood,B-Reason
105027,thinner,I-Reason
105027,",",I-Reason
105027,while,O
105027,we,O
105027,await,O
105027,your,O
105027,coumadin,B-Drug
105027,level,O
105027,to,O
105027,be,O
105027,therapeutic,O
105027,.,O
105027,You,O
105027,will,O
105027,need,O
105027,to,O
105027,see,O
105027,a,O
105027,hematologist,O
105027,as,O
105027,an,O
105027,outpatient,O
105027,to,O
105027,complete,O
105027,your,O
105027,clotting,O
105027,disorder,O
105027,workup,O
105027,.,O
105027,You,O
105027,had,O
105027,fevers,O
105027,in,O
105027,the,O
105027,hospital,O
105027,.,O
105027,Because,O
105027,of,O
105027,the,O
105027,imaging,O
105027,findings,O
105027,in,O
105027,your,O
105027,kidney,O
105027,we,O
105027,could,O
105027,not,O
105027,rule,O
105027,out,O
105027,a,O
105027,kidney,O
105027,infection,O
105027,.,O
105027,Therefore,O
105027,",",O
105027,you,O
105027,received,O
105027,14,O
105027,days,O
105027,of,O
105027,therapy,O
105027,for,O
105027,a,O
105027,presumed,O
105027,kidney,O
105027,infection,O
105027,.,O
105027,You,O
105027,completed,O
105027,this,O
105027,prior,O
105027,to,O
105027,discharge,O
105027,.,O
105027,Your,O
105027,continued,O
105027,fevers,O
105027,and,O
105027,pain,O
105027,are,O
105027,likely,O
105027,due,O
105027,to,O
105027,an,O
105027,inflammatory,O
105027,reaction,O
105027,as,O
105027,your,O
105027,body,O
105027,breaks,O
105027,down,O
105027,the,O
105027,portions,O
105027,of,O
105027,kidney,O
105027,tissue,O
105027,that,O
105027,died,O
105027,.,O
105027,You,O
105027,can,O
105027,take,O
105027,acetaminophen,B-Drug
105027,for,O
105027,these,O
105027,fevers,B-Reason
105027,as,O
105027,needed,O
105027,.,O
105027,Unfortunately,O
105027,",",O
105027,this,O
105027,inflammatory,O
105027,reaction,O
105027,also,O
105027,causes,O
105027,pain,B-Reason
105027,",",I-Reason
105027,which,O
105027,we,O
105027,have,O
105027,treated,O
105027,with,O
105027,multiple,O
105027,pain,B-Drug
105027,medicines,I-Drug
105027,.,I-Drug
105027,You,O
105027,will,O
105027,need,O
105027,follow,O
105027,up,O
105027,with,O
105027,a,O
105027,primary,O
105027,care,O
105027,provider,O
105027,and,O
105027,coumadin,B-Drug
105027,clinic,O
105027,to,O
105027,follow,O
105027,how,O
105027,thin,O
105027,your,O
105027,blood,O
105027,is,O
105027,.,O
105027,You,O
105027,will,O
105027,also,O
105027,need,O
105027,follow,O
105027,up,O
105027,with,O
105027,a,O
105027,kidney,O
105027,doctor,O
105027,to,O
105027,follow,O
105027,your,O
105027,kidney,O
105027,function,O
105027,",",O
105027,a,O
105027,hematologist,O
105027,to,O
105027,assess,O
105027,you,O
105027,for,O
105027,a,O
105027,predisposition,O
105027,to,O
105027,clotting,O
105027,and,O
105027,help,O
105027,manage,O
105027,this,O
105027,",",O
105027,and,O
105027,a,O
105027,rheumatologist,O
105027,as,O
105027,some,O
105027,of,O
105027,your,O
105027,tests,O
105027,suggest,O
105027,a,O
105027,possible,O
105027,autoimmune,O
105027,disorder,O
105027,.,O
105027,We,O
105027,have,O
105027,scheduled,O
105027,these,O
105027,appointments,O
105027,for,O
105027,you,O
105027,.,O
105027,Your,O
105027,medications,O
105027,have,O
105027,been,O
105027,changed,O
105027,.,O
105027,You,O
105027,have,O
105027,been,O
105027,started,O
105027,on,O
105027,coumadin,B-Drug
105027,",",I-Drug
105027,a,O
105027,blood,B-Reason
105027,thinner,I-Reason
105027,",",I-Reason
105027,that,O
105027,you,O
105027,will,O
105027,need,O
105027,to,O
105027,take,O
105027,until,O
105027,your,O
105027,are,O
105027,told,O
105027,to,O
105027,stop,O
105027,by,O
105027,a,O
105027,doctor,O
105027,.,O
105027,Your,O
105027,blood,O
105027,has,O
105027,not,O
105027,yet,O
105027,been,O
105027,thinned,O
105027,enough,O
105027,by,O
105027,coumadin,B-Drug
105027,so,O
105027,you,O
105027,are,O
105027,also,O
105027,being,O
105027,discharged,O
105027,on,O
105027,ENOXAPARIN,B-Drug
105027,(,I-Drug
105027,LOVENOX,O
105027,),O
105027,",",O
105027,which,O
105027,will,O
105027,keep,O
105027,your,O
105027,blood,O
105027,thin,O
105027,until,O
105027,your,O
105027,coumadin,B-Drug
105027,levels,O
105027,are,O
105027,adequate,O
105027,.,O
105027,When,O
105027,your,O
105027,coumadin,B-Drug
105027,levels,O
105027,are,O
105027,adequate,O
105027,for,O
105027,24,O
105027,hours,O
105027,you,O
105027,can,O
105027,stop,O
105027,the,O
105027,enoxaparin,B-Drug
105027,.,I-Drug
105027,You,O
105027,have,O
105027,also,O
105027,been,O
105027,started,O
105027,on,O
105027,MORPHINE,B-Drug
105027,sustained,O
105027,release,O
105027,and,O
105027,immediate,B-Form
105027,release,I-Form
105027,for,O
105027,pain,B-Reason
105027,.,I-Reason
105027,You,O
105027,should,O
105027,not,O
105027,drive,O
105027,while,O
105027,using,O
105027,these,O
105027,medications,O
105027,as,O
105027,they,O
105027,can,O
105027,make,O
105027,you,O
105027,sleepy,B-ADE
105027,.,I-ADE
105027,You,O
105027,were,O
105027,also,O
105027,started,O
105027,on,O
105027,GABAPENTIN,B-Drug
105027,(,O
105027,NEURONTIN,B-Drug
105027,),I-Drug
105027,to,O
105027,help,O
105027,manage,O
105027,your,O
105027,pain,B-Reason
105027,.,I-Reason
105027,Please,O
105027,seek,O
105027,immediate,O
105027,medical,O
105027,attention,O
105027,if,O
105027,you,O
105027,experience,O
105027,chest,O
105027,pain,O
105027,",",O
105027,shortness,O
105027,of,O
105027,breath,O
105027,",",O
105027,abdominal,O
105027,pain,O
105027,",",O
105027,or,O
105027,any,O
105027,change,O
105027,from,O
105027,your,O
105027,baseline,O
105027,health,O
105027,status,O
105027,Followup,O
105027,Instructions,O
105027,:,O
105027,MD,O
105027,:,O
105027,[,O
105027,**First,O
105027,Name8,O
105027,(,O
105027,NamePattern2,O
105027,),O
105027,**,O
105027,],O
105027,[,O
105027,**Last,O
105027,Name,O
105027,(,O
105027,NamePattern1,O
105027,),O
105027,**,O
105027,],O
105027,",",O
105027,MD,O
105027,Specialty,O
105027,:,O
105027,PCP,O
105027,Date,O
105027,and,O
105027,time,O
105027,:,O
105027,Friday,O
105027,",",O
105027,[,O
105027,**2125-10-12**,O
105027,],O
105027,at,O
105027,1:45,O
105027,pm,O
105027,Location,O
105027,:,O
105027,[,O
105027,**Location,O
105027,(,O
105027,un,O
105027,),O
105027,**,O
105027,],O
105027,",",O
105027,[,O
105027,**Hospital,O
105027,Ward,O
105027,Name,O
105027,23**,O
105027,],O
105027,Bldg,O
105027,",",O
105027,[,O
105027,**Location,O
105027,(,O
105027,un,O
105027,),O
105027,**,O
105027,],O
105027,Phone,O
105027,number,O
105027,:,O
105027,[,O
105027,**Telephone/Fax,O
105027,(,O
105027,1,O
105027,),O
105027,250**,O
105027,],O
105027,MD,O
105027,:,O
105027,[,O
105027,**First,O
105027,Name4,O
105027,(,O
105027,NamePattern1,O
105027,),O
105027,**,O
105027,],O
105027,[,O
105027,**Last,O
105027,Name,O
105027,(,O
105027,NamePattern1,O
105027,),O
105027,1366**,O
105027,],O
105027,Specialty,O
105027,:,O
105027,Nephrology,O
105027,Date,O
105027,and,O
105027,time,O
105027,:,O
105027,Wednesday,O
105027,",",O
105027,[,O
105027,**2128-11-7**,O
105027,],O
105027,:00,O
105027,Location,O
105027,:,O
105027,[,O
105027,**Location,O
105027,(,O
105027,un,O
105027,),O
105027,**,O
105027,],O
105027,",",O
105027,[,O
105027,**Hospital,O
105027,Ward,O
105027,Name,O
105027,23**,O
105027,],O
105027,Bldg,O
105027,",",O
105027,[,O
105027,**Location,O
105027,(,O
105027,un,O
105027,),O
105027,436**,O
105027,],O
105027,Phone,O
105027,number,O
105027,:,O
105027,[,O
105027,**Telephone/Fax,O
105027,(,O
105027,1,O
105027,),O
105027,721**,O
105027,],O
105027,MD,O
105027,:,O
105027,[,O
105027,**First,O
105027,Name8,O
105027,(,O
105027,NamePattern2,O
105027,),O
105027,**,O
105027,],O
105027,[,O
105027,**Last,O
105027,Name,O
105027,(,O
105027,NamePattern1,O
105027,),O
105027,6944**,O
105027,],O
105027,Specialty,O
105027,:,O
105027,Hematology,O
105027,Date,O
105027,and,O
105027,time,O
105027,:,O
105027,Wednesday,O
105027,",",O
105027,[,O
105027,**Month,O
105027,(,O
105027,only,O
105027,),O
105027,1096**,O
105027,],O
105027,Location,O
105027,:,O
105027,[,O
105027,**Location,O
105027,(,O
105027,un,O
105027,),O
105027,**,O
105027,],O
105027,",",O
105027,[,O
105027,**Hospital,O
105027,Ward,O
105027,Name,O
105027,23**,O
105027,],O
105027,Bldg,O
105027,",",O
105027,[,O
105027,**Location,O
105027,(,O
105027,un,O
105027,),O
105027,436**,O
105027,],O
105027,Phone,O
105027,number,O
105027,:,O
105027,[,O
105027,**Telephone/Fax,O
105027,(,O
105027,1,O
105027,),O
105027,68451**,O
105027,],O
